Corcept Therapeutics | CORT - Ebit



Corcept Therapeutics reported $26.67M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Acadia Pharmaceuticals USD 32.37M 13.08M Jun/2025
Alaunos Therapeutics USD -7949000 715K Dec/2023
ANI Pharmaceuticals USD 15.17M 10.3M Jun/2025
Ardelyx USD -12503000 20.63M Jun/2025
Aurora Cannabis CAD -17609000 54.46M Jun/2025
BioMarin Pharmaceutical USD 276.89M 52.99M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Canopy Growth CAD -31497000 7.68M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
J&J USD 6.94B 443M Jun/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Merck USD 6.36B 149M Jun/2025
Novartis USD -9190000000 13.87B Jun/2025
Novartis USD 4.82B 39M Jun/2025
Pacira USD 10.23M 2.21M Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
TG Therapeutics USD 34.84M 22.62M Jun/2025